Manolo Bellotto
Corporate Officer/Principal chez GAIN THERAPEUTICS, INC.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Matthias Alder | M | 59 |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 3 ans |
| Jeffrey Riley | M | 61 |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 5 ans |
| Khalid Islam | M | 67 |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 7 ans |
| Gianluca Fuggetta | M | 35 | 2 ans | |
| Dov Goldstein | M | 56 | 3 ans | |
| Eric Richman | M | 63 | 4 ans | |
| Gwen Melincoff | M | 72 | 3 ans | |
| Hans-Peter Hasler | M | 68 | 3 ans | |
| Claude Nicaise | M | 71 | 3 ans | |
| Elena Cubero-Jorda | F | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Charles Ballantyne | M | 64 | 1 ans | |
| Robert Peugeot | M | 74 | 11 ans | |
| Rainer-Marc Frey | M | 61 | 10 ans | |
| Salvatore Calabrese | M | 54 | 3 ans | |
| Lorenzo Leoni | M | - | 4 ans | |
| Roberto de Ponti | M | - |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 1 ans |
| Roberto Barzi | M | 48 | 2 ans | |
| Somboon Prasitjutrakul | M | 65 | - | |
| Charles Toomey | M | 62 | - | |
| Kevin Doyle Corning | M | - | 4 ans | |
| Xavier Barril | M | - | 6 ans | |
| Marianne Bjordal | M | - | 1 ans | |
| Ana Maria Garcia-Collazo | M | - | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 17 | 73,91% |
| Suisse | 9 | 39,13% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Manolo Bellotto
- Réseau Personnel
